Non-viral gene transfer in hydrogel matrices with octacalcium phosphate microgranules in optimization of reparative osteogenesis


Cite item

Full Text

Abstract

There is a strong unmet need for bone grafts and substitutes combining osteoinductive capacities and biophysical properties for using them in minimally invasive surgical interventions. We have developed three variants of injectable gene-activated bone substitutes containing three components: octacalcium phosphate microgranules (OCP), plasmid DNA delivering the gene of vascular endothelial growth factor, and one of the hydrogels based on sodium alginate, type I collagen, and hyaluronic acid. The molecules of the gene constructs were contained both in the hydrogel and on the surface of the OCP microgranules. In the model of a critical-sized bone defect in rabbit parietal bone, we found that all the gene-activated hydrogels contributed to bone tissue regeneration, however, the largest amount of newly formed bone, including those in the central part of the defect, was detected in the groups with gene-activated materials based on hyaluronic acid and collagen. Thus, the developed materials can be considered as candidates for medical devices, but additional studies are required to assess the dose-depended effect and optimize the materials composition.

Full Text

Restricted Access

About the authors

I. Y Bozo

Histograft, LLC; Research Institute of General Pathology and Pathophysiology; A.I. Burnazyana Federal Medical Biophysical Center, FMBA of Russia

E. V Presnyakov

I.I. Mechnikov North-Western State Medical University

E. S Rochev

First I.P. Pavlov Saint Petersburg Medical University

V. V Tserceil

I.I. Mechnikov North-Western State Medical University

P. S Podluzny

I.I. Mechnikov North-Western State Medical University

M. O Mavlikeev

I.I. Mechnikov North-Western State Medical University

A. Yu Fedotov

A.A. Baikov Institute of Metallurgy and Materials Science, Russian Academy of Sciences

O. V Baranov

A.A. Baikov Institute of Metallurgy and Materials Science, Russian Academy of Sciences

I. I Eremin

Research Institute of General Pathology and Pathophysiology; National Research Center “Kurchatov Institute"

A. A Pulin

Research Institute of General Pathology and Pathophysiology; Kazan (Volga Region] Federal University

T. S Chauzova

Research Institute of General Pathology and Pathophysiology

A. P Petrikina

Research Institute of General Pathology and Pathophysiology

A. I Bilyalov

N.I. Pirogov National Medical and Surgical Center

A. A Titova

N.I. Pirogov National Medical and Surgical Center

A. A Isaev

Institute of Human Stem Cells, PJSC

V. S Komlev

A.A. Baikov Institute of Metallurgy and Materials Science, Russian Academy of Sciences

R. V Deev

Histograft, LLC; I.I. Mechnikov North-Western State Medical University; Institute of Human Stem Cells, PJSC

References

  1. Shimamura M., Nakagami H., Sanada F., et al. Progress of Gene Therapy in Cardiovascular Disease. Hypertension. 2020; 76(4): 1038-1044.
  2. Kukuta K., Urbanowicz A., Ktopotowski M., et al. Long-term follow-up and safety assessment of angiogenic gene therapy trial VlF-CAD: Transcatheter intramyocardial administration of a bicistronic plasmid expressing VEGF-A165/bFGF cDNA for the treatment of refractory coronary artery disease. Am Heart J. 2019; 215:78-82.
  3. Kolk A., Boskov M., Haidari S., et al.Comparative analysis of bone regeneration behavior using recombinant human BMP-2 versus plasmid DNA of BMP-2. J Biomed Mater Res A. 2019; 107(1):163-173.
  4. Deev R., Bozo I., Isaev A., et al. Results of 5-year follow-up study in patients with peripheral artery disease treated with PL-VEGF165 for intermittent claudication. Ther Adv Cardiovasc Dis. 2018;12(9): 237-246.
  5. Kalinin R.E., Suchkov I.A., Deev R.V., et al. Gene-mediated induction of angiogenesis in inoperable patients with atherosclerosis and diabetes mellitus. Angiol Sosud Khir. 2018; 24(2):33-40.
  6. Bozo I.Y., Drobyshev A.Y., Redko N.A., et al. Bringing a Gene-Activated Bone Substitute Into Clinical Practice: From Bench to Bedside. Front Bioeng Biotechnol. 2021; 9:599300
  7. Sallent I., Capella-Monsonis H., Procter P., et al. The Few Who Made It: Commercially and Clinically Successful Innovative Bone Grafts. Front Bioeng Biotechnol. 2020; 8:952.
  8. Hasani-Sadrabadi M.M., Sarrion P., Pouraghaei S., et al. An engineered cell-laden adhesive hydrogel promotes craniofacial bone tissue regeneration in rats. Sci Transl Med. 2020 Mar 11;12(534): eaay6853.
  9. Krishnan L., Priddy L.B., Esancy C., et al. Hydrogel-based Delivery of rhBMP-2 Improves Healing of Large Bone Defects Compared With Autograft. Clin Orthop Relat Res. 2015; 473(9):2885-97.
  10. Wang P., Huang S., Hu Z., et al. In situ formed anti-inflammatory hydrogel loading plasmid DNA encoding VEGF for burn wound healing. Acta Biomater. 2019;100:191-201.
  11. Wang W., Tan B., Chen J., et al. An injectable conductive hydrogel encapsulating plasmid DNA-eNOs and ADSCs for treating myocardial infarction. Biomaterials. 2018; 160:69-81.
  12. Li H., Ji Q., Chen X., et al. Accelerated bony defect healing based on chitosan thermosensitive hydrogel scaffolds embedded with chitosan nanoparticles for the delivery of BMP2 plasmid DNA. J Biomed Mater Res A. 2017; 105(1):265-273.
  13. Bozo I.Y., Mavlikeev M.O., Presnyakov E.V., et al. Gene-Activated Hydrogels Based on Sodium Alginate for Reparative Myogenesis of Skeletal Muscle. Inorganic Materials: Applied Research 2021; 12:1026-1032.

Copyright (c) 2021 PJSC Human Stem Cells Institute


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: ПИ № ФС 77 - 57156 от 11.03.2014.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies